Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guangzhou Jet Biofiltration CoSHSE:688026 -1.82%74 5-Year Yield-on-Cost % is 0.07 as of Sep. 10, 2026, which is 42% below its 10-year median of 0.12. GuruFocus rates SHSE:688026 with a GF Score™ of 74/100 and a GF Value™ of ¥17.67 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 314 Medical Devices & Instruments companies, Guangzhou Jet Biofiltration Co ranks worse than 99.04% on this metric.
The historical rank and industry rank for Guangzhou Jet Biofiltration Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:688026'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.03 Med: 0.12 Max: 0.79
Current: 0.07
During the past 13 years, Guangzhou Jet Biofiltration Co's highest Yield on Cost was 0.79. The lowest was 0.03. And the median was 0.12.
SHSE:688026's 5-Year Yield-on-Cost % is ranked worse than 99.04% of 314
companies
in the Medical Devices & Instruments industry
Industry Median: 2.475
vs SHSE:688026: 0.07
Guangzhou Jet Biofiltration Co (SHSE:688026) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Guangzhou Jet Biofiltration Co 5-Year Yield-on-Cost % Related Terms
SHSE:688026 vs ISRG, BDX, RMD: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Guangzhou Jet Biofiltration Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou Jet Biofiltration Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Guangzhou Jet Biofiltration Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Guangzhou Jet Biofiltration Co's 5-Year Yield-on-Cost % falls into.
Guangzhou Jet Biofiltration Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Guangzhou Jet Biofiltration Co (SHSE:688026) has a 5-Year Yield-on-Cost % of 0.07 as of Sep. 10, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Guangzhou Jet Biofiltration Co and its competitors. This is 42% below median its historical median of 0.12. Over the past decade, Guangzhou Jet Biofiltration Co's 5-Year Yield-on-Cost % has ranged from 0.03 to 0.79. According to the industry distribution chart, Guangzhou Jet Biofiltration Co ranks #311 out of 314 companies in the Medical Devices & Instruments industry, placing it in the top 99%.
Is Guangzhou Jet Biofiltration Co's 5-Year Yield-on-Cost % too high?
Guangzhou Jet Biofiltration Co's current 5-Year Yield-on-Cost % of 0.07 is 42% below median its 10-year median of 0.12. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.79. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.48. Guangzhou Jet Biofiltration Co's value of 0.07 is 97.2% below this industry median. Based on the distribution chart, Guangzhou Jet Biofiltration Co ranks #311 out of 314 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Guangzhou Jet Biofiltration Co has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Jet Biofiltration Co's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Guangzhou Jet Biofiltration Co ranks #311 out of 314 companies for 5-Year Yield-on-Cost %. This places Guangzhou Jet Biofiltration Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.48. Guangzhou Jet Biofiltration Co's value of 0.07 is 97.2% below this benchmark. Historically, Guangzhou Jet Biofiltration Co's own 5-Year Yield-on-Cost % has ranged from 0.03 to 0.79 over the past decade. While the company's 10-year median is 0.12 vs. the industry median of 2.48, Guangzhou Jet Biofiltration Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.48, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Jet Biofiltration Co's current 5-Year Yield-on-Cost % of 0.07 is 97.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Guangzhou Jet Biofiltration Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Jet Biofiltration Co's current 5-Year Yield-on-Cost % is 0.07, which is 42% below median its own 10-year median of 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Jet Biofiltration Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co (SHSE:688026) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥17.67, compared to a current price of ¥21.63 — trading 22.4% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.07, which is 42% below median its 10-year median of 0.12 and 97.2% below the Medical Devices & Instruments industry median of 2.48. Guangzhou Jet Biofiltration Co's overall GF Score™ is 74/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Guangzhou Jet Biofiltration Co (SHSE:688026), the current 5-Year Yield-on-Cost % is 0.07 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Jet Biofiltration Co (SHSE:688026) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co stock appears to be overvalued.
The current stock price of ¥21.63 is trading 22.4% above its estimated GF Value™ of ¥17.67.
GuruFocus considers Guangzhou Jet Biofiltration Co to be Modestly Overvalued.
Key valuation signals for SHSE:688026:
5-Year Yield-on-Cost %: 0.07 (42% below median its 10-year median of 0.12)
GF Value™: ¥17.67 vs. price of ¥21.63 (22.4% above fair value)
Industry Position: 97.2% below the Medical Devices & Instruments median (#311 of 314)
No single metric tells the full story. See the SHSE:688026 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou Jet Biofiltration Co Ltd is engaged in the research and development, manufacturing and sales of laboratory consumable products. Its main products include laboratory consumables (pipettes, tissue culture products, centrifuge tubes, filtration products) analyzer, lab equipment and others.
74GF Score
Get the complete analysis for SHSE:688026
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688026 has been successfully added to your 
